Yale Researchers Develop mRNA-Based Lyme Disease Vaccine

+ Retirely on ›

Yale University researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme disease and may also combat other tick-borne diseases. Instead of triggering an immune response against a particular pathogen, the new vaccine prompts a quick response in the skin to components of tick saliva, […]

The post Yale Researchers Develop mRNA-Based Lyme Disease Vaccine appeared first on Good News Network.

The Briefing

Liked this? Get stories like it by email

Top stories, market moves and new columns from our advisors, in one short email.

Confirm by email, unsubscribe in one click. What you'll get

Leave a Reply

Your email address will not be published. Required fields are marked *

AboutTermsPrivacyNewsInvestorsAdvisorsLogin
Dark mode